Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218237 · ClinicalTrials.gov registry record · NA
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
A NA study, sponsored by Medical College of Wisconsin.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07218237: Clinical Trial NA study, sponsored by Medical College of Wisconsin.
NCT07218237 is a NA study that has not yet begun recruiting, run by Medical College of Wisconsin. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218237, a NA study, has not yet begun recruiting, sponsored by Medical College of Wisconsin.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.
Primary Outcome
Assess study feasibility as measured by retention rate
Interventions
- BEHAVIORAL Mindfulness training
- BEHAVIORAL Garmin Vivoactive 4 watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-03 |
| Est. Completion | 2028-10 |
| Phase | NA |
What is known before NCT07218237 opens enrollment
NCT07218237 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Mindfulness training is the first listed.
NCT07218237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07218237 about?
NCT07218237 is a clinical study titled "Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy". The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster se...
What is the current status of trial NCT07218237?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-03. Estimated completion is 2028-10.
What interventions are being tested in trial NCT07218237?
The interventions under investigation include: Mindfulness training (BEHAVIORAL), Garmin Vivoactive 4 watch (BEHAVIORAL).
Who is sponsoring clinical trial NCT07218237?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07218237's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia